This high expression of BDP1 correlating with poor survival is in contrast with the observed decrease of BDP1 expression in serous ovarian cancer presented in Figure 2 and the negative BDP1 expression correlating with increased stage in serous ovarian cancer as demonstrated in Figure 3. This evidence concerns the gene BDP1 and ovarian serous adenocarcinoma.